Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. [PDF]
Manuck TA +11 more
europepmc +1 more source
Correction: Prevention of spontaneous preterm birth. [PDF]
Daskalakis G +6 more
europepmc +1 more source
Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. [PDF]
Caritis SN +18 more
europepmc +1 more source
The Use of Routine Laboratory 17-Hydroxyprogesterone for Identification of Cases of 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia. [PDF]
McElvaney J +7 more
europepmc +1 more source
21-deoxycortisol as a second-tier test in congenital adrenal hyperplasia newborn screening in The Netherlands: two-year evaluation. [PDF]
Olthof A +7 more
europepmc +1 more source
Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. [PDF]
Manuck TA +4 more
europepmc +1 more source
Adrenal Venous Sampling Aids in Distinguishing 17-Hydroxyprogesterone Hypersecreting Adrenal Cortical Adenomas from Non-Classical 21-Hydroxylase Deficiency. [PDF]
Qiu R, Yang T, Shang C, Zhu W, Zheng F.
europepmc +1 more source
Two Distinct Endocrine Conditions in a Single Pediatric Patient: Congenital Adrenal Hyperplasia and Type 1 Diabetes Mellitus. [PDF]
Gomes C +4 more
europepmc +1 more source
Uncontrolled hypertension in siblings: an unsuspected diagnosis. [PDF]
Aleem S +3 more
europepmc +1 more source
Delayed Diagnosis of Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency. [PDF]
Yousaf S +5 more
europepmc +1 more source

